fluorodeoxyglucose f18 has been researched along with Cacosmia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaldi, D; Barisione, E; Bauckneht, M; Benedetti, L; Biassoni, E; Chiola, S; D'amico, F; Donegani, MI; Gianmario, S; Lanfranchi, F; Mancini, R; Miceli, A; Morbelli, S; Nobili, F; Orso, B; Pardini, M | 1 |
| Ceccaldi, M; Eldin, C; Guedj, E; Hautefort, C; Kas, A; Lazarini, F; Morbelli, S; Radulesco, T; Salmon-Ceron, D | 1 |
| Adriaanse, SM; Booij, J; Depboylu, C; Heinen, L; Höffken, H; Kesper, K; Leenders, KL; Luster, M; Mayer, G; Meles, SK; Oertel, WH; Overeem, S; Pijpers, A; Reesink, FE; Reetz, K; Renken, RJ; Sittig-Wiegand, E; Teune, LK; Vadasz, D; van Laar, T | 1 |
| Alessandrini, M; Chiaravalloti, A; Danieli, R; Micarelli, A; Schillaci, O | 1 |
| Bressman, S; Brüggemann, N; Condefer, K; Dhawan, V; Hagenah, J; Klein, C; Kornreich, R; Ozelius, L; Palmese, C; Pastores, G; Roe, A; Sathe, S; Saunders-Pullman, R; Stanley, K; Tagliati, M | 1 |
| Bartenstein, P; Buerger, K; Cumming, P; Förster, S; Hampel, H; Hummel, T; Hundt, W; la Fougère, C; Mustafa, M; Rominger, A; Steinbach, S; Teipel, SJ; Vaitl, A; Yakushev, I | 1 |
| Hummel, T; Kitzler, H; Landis, B; Mueller, A; Reichmann, H; Reuner, U | 1 |
7 other study(ies) available for fluorodeoxyglucose f18 and Cacosmia
| Article | Year |
|---|---|
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
Topics: Anosmia; COVID-19; Fluorodeoxyglucose F18; Humans; Olfaction Disorders; Parkinson Disease; RNA, Viral; SARS-CoV-2; Smell | 2022 |
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Memory Disorders; Olfaction Disorders; Olfactory Bulb; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals | 2021 |
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
Topics: Aged; Analysis of Variance; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2017 |
Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation.
Topics: Adult; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Olfaction Disorders; Pilot Projects; Positron-Emission Tomography; Smell | 2017 |
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Phenotype; Positron-Emission Tomography; Ultrasonography, Doppler, Transcranial | 2010 |
Functional representation of olfactory impairment in early Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Odorants; Olfaction Disorders; Positron-Emission Tomography; Smell | 2010 |
Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Chromosome Aberrations; Copper; Extrapyramidal Tracts; Female; Fluorodeoxyglucose F18; Genes, Recessive; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Olfaction Disorders; Olfactory Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Sensory Thresholds; Statistics as Topic | 2006 |